scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1104333900 |
P356 | DOI | 10.1038/S41374-018-0063-2 |
P932 | PMC publication ID | 6528473 |
P698 | PubMed publication ID | 29858580 |
P50 | author | Orson W Moe | Q87611844 |
Ming Chang Hu | Q88663862 | ||
P2093 | author name string | Mingjun Shi | |
Junxia Wu | |||
Brianna Flores | |||
Nancy Gillings | |||
Kathryn L McMillan | |||
P2860 | cites work | Suppression of aging in mice by the hormone Klotho | Q24650916 |
The aging kidney: increased susceptibility to nephrotoxicity | Q26824198 | ||
Alpha Klotho and phosphate homeostasis | Q26825471 | ||
Can serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysis | Q26851216 | ||
Klotho and phosphate are modulators of pathologic uremic cardiac remodeling | Q27342649 | ||
Chronic Kidney Disease, Gender, and Access to Care: A Global Perspective | Q30234394 | ||
Acute Kidney Injury in Western Countries | Q30240194 | ||
World incidence of AKI: a meta-analysis | Q30410807 | ||
Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review | Q33403723 | ||
The late histologic findings in diarrhea-associated hemolytic uremic syndrome | Q33503373 | ||
FGF23 induces left ventricular hypertrophy | Q34028891 | ||
Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule | Q34072230 | ||
Fluorescence microangiography for quantitative assessment of peritubular capillary changes after AKI in mice | Q34103499 | ||
MicroRNA-34a is induced via p53 during cisplatin nephrotoxicity and contributes to cell survival | Q34112716 | ||
Klotho deficiency causes vascular calcification in chronic kidney disease | Q34457281 | ||
Mitochondrial dysregulation and protection in cisplatin nephrotoxicity | Q34762287 | ||
Lipid peroxides and antioxidant enzymes in cisplatin-induced chronic nephrotoxicity in rats | Q34894354 | ||
The demonstration of αKlotho deficiency in human chronic kidney disease with a novel synthetic antibody | Q35022247 | ||
Klotho deficiency is an early biomarker of renal ischemia–reperfusion injury and its replacement is protective | Q35611229 | ||
Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors | Q35958459 | ||
Gender differences in hypertension and kidney disease | Q36065332 | ||
Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. | Q36104887 | ||
Drug-induced acute kidney injury in children | Q36125552 | ||
Phosphate-Induced Renal Fibrosis Requires the Prolyl Isomerase Pin1 | Q36620380 | ||
Repeated administration of low-dose cisplatin in mice induces fibrosis | Q36698742 | ||
Three-Dimensional Morphology by Multiphoton Microscopy with Clearing in a Model of Cisplatin-Induced CKD. | Q36746084 | ||
Loss of Klotho contributes to kidney injury by derepression of Wnt/β-catenin signaling | Q36796604 | ||
Long-term nephrotoxicity in adult survivors of childhood cancer | Q36910939 | ||
Long-Term Renal Outcomes after Cisplatin Treatment | Q37069974 | ||
Gender difference in Cisplatin-induced nephrotoxicity in a rat model: greater intensity of damage in male than female | Q37316465 | ||
Phosphate levels and cardiovascular disease in the general population | Q37474054 | ||
Risk factors of gender for renal progression in patients with early chronic kidney disease | Q37605595 | ||
Klotho has dual protective effects on cisplatin-induced acute kidney injury | Q37678608 | ||
Changes in macroautophagy, chaperone-mediated autophagy, and mitochondrial metabolism in murine skeletal and cardiac muscle during aging. | Q37715514 | ||
The influence of gender and sexual hormones on incidence and outcome of chronic kidney disease | Q37902094 | ||
Phosphate in early chronic kidney disease: associations with clinical outcomes and a target to reduce cardiovascular risk | Q38009044 | ||
Klotho as a potential biomarker and therapy for acute kidney injury | Q38016065 | ||
The role of phosphate in kidney disease | Q38793054 | ||
Sex and gender differences in chronic kidney disease: progression to end-stage renal disease and haemodialysis. | Q38851203 | ||
Potential application of klotho in human chronic kidney disease | Q39003568 | ||
Epidemiology of acute kidney injury in the intensive care unit | Q39657598 | ||
Methods of reduction of cisplatin nephrotoxicity. | Q40128271 | ||
CD4 T cell knockout does not protect against kidney injury and worsens cancer | Q40260014 | ||
Aging-associated metabolic disorder induces Nox2 activation and oxidative damage of endothelial function | Q41014338 | ||
αKlotho Mitigates Progression of AKI to CKD through Activation of Autophagy | Q42123327 | ||
Age-dependent role of microvascular endothelial and polymorphonuclear cells in lipopolysaccharide-induced acute kidney injury. | Q42507066 | ||
Phosphate and CVD: it's all in what's on the table | Q43102878 | ||
The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. | Q46891097 | ||
Glomerular function time trends in long-term survivors of childhood cancer: a longitudinal study | Q48163446 | ||
Cisplatin nephrotoxicity in rats: defect in papillary hypertonicity | Q49120119 | ||
Gender differences in adenine-induced chronic kidney disease and cardiovascular complications in rats. | Q51114166 | ||
Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy. | Q51164635 | ||
Incidence and outcomes in acute kidney injury: a comprehensive population-based study. | Q51765594 | ||
Developing better mouse models to study cisplatin-induced kidney injury. | Q53154188 | ||
Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition. | Q53289364 | ||
Phosphate excretion is decreased in older cardiac patients with normal kidney function: an emerging dietary risk factor? | Q55027071 | ||
Renal tight junction proteins are decreased in cisplatin-induced nephrotoxicity in rats. | Q55072805 | ||
Klotho/FGF23 Axis in Chronic Kidney Disease and Cardiovascular Disease. | Q55442487 | ||
Atubular glomeruli in cisplatin-induced chronic interstitial nephropathy. An experimental stereological investigation | Q68668714 | ||
Nephrotoxicity of cisplatin in rats | Q69784982 | ||
Cis-diamminedichlorplatinum-induced acute renal failure in the rat | Q70676375 | ||
Lack of age-dependent cisplatin nephrotoxicity | Q70791012 | ||
Age differences in cisplatinum nephrotoxicity | Q70797817 | ||
Plasma platinum levels: relationship to cisplatin dose and nephrotoxicity | Q71228108 | ||
Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study | Q80212537 | ||
Epidemiology of acute kidney injury | Q80541404 | ||
Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury | Q82891406 | ||
Yes, AKI truly leads to CKD | Q83880177 | ||
Self-eating for death or survival during cisplatin nephrotoxicity? | Q84716943 | ||
Alterations in Cisplatin Pharmacokinetics and Its Acute/Sub-chronic Kidney Injury over Multiple Cycles of Cisplatin Treatment in Rats | Q89798733 | ||
Cis-diamminedichloroplatinum (II)-induced acute renal failure in the rat. Correlation of structural and functional alterations | Q93606695 | ||
P433 | issue | 8 | |
P1104 | number of pages | 17 | |
P304 | page(s) | 1105-1121 | |
P577 | publication date | 2018-06-01 | |
P1433 | published in | Laboratory Investigation | Q6467260 |
P1476 | title | Cisplatin nephrotoxicity as a model of chronic kidney disease | |
P478 | volume | 98 |
Q90162033 | Cardiac Remodeling in Chronic Kidney Disease |
Q90055591 | Evaluation of the Protective Effect of Cystone Against Cisplatin-induced Nephrotoxicity in Patients with Cancer: A Pilot Study |
Q99711241 | High Phosphate Induces and Klotho Attenuates Kidney Epithelial Senescence and Fibrosis |
Q92668491 | Interaction between the autophagy protein Beclin 1 and Na+,K+-ATPase during starvation, exercise, and ischemia |
Q92940669 | Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury |
Search more.